(Rijeka: IntechOpen)
Durante o STEP UP, que contou com 1.407 participantes sem diabetes tipo 2, e o STEP UP T2D, que analisou os efeitos em 512 participantes com diabetes tipo 2, estes adultos com obesidade tomaram uma dose de 7,2 mg uma vez por semana, juntamente com mudanas no estilo de vida, e perderam consideravelmente mais peso do que as pessoas que receberam placebo
Ozempic specifically harnesses the power of Semaglutide to target the improvement of glycemic control in adults with type 2 diabetes , adhering to its primary approval
Neurosci Lett 569:7479 Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
[1] [12] Interestingly, emerging research suggests that GLP-1 receptor agonists may actually have neuroprotective properties , though this remains investigational